BX-471

N/A

Report date: 2023/11/30 11:28:37
NME

Base Information

Drug NameBX-471
Drug Alias NameCCR1 - Bayer HealthcareCCR1 antagonist - Bayer HealthcareBX-471SH-T-04268HSHT-04268H +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 1 antagonistsRadionuclide imaging enhancers
TargetsC-C chemokine receptor type 1
Therapy Area/IndicationsEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSwedenNetherlands +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsEndometriosis

Other Information

ATC CodeN/A
Related LinksN/A